Recent Company News

• 05:30 PM ET Oct 31, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 08:54 AM ET Oct 31, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 01:17 AM ET Oct 31, 2025
  

  Bicycle Therapeutics downgraded to sector perform from outperform at RBC Capital Markets ($8.76, 0.00)

• 07:16 AM ET Oct 30, 2025
  

  Bicycle Therapeutics reports Q3 EPS ($0.85) vs FactSet ($1.08) [13 est, ($1.27)-(0.74)] ($8.18, 0.00)

• 04:09 PM ET Aug 08, 2025
  

  Bicycle Therapeutics files $500M mixed securities shelf; registers ~30.3M ADSs for resale by selling holders - S-3 ($7.65, 0.00)

• 07:05 AM ET Aug 08, 2025
  

  Bicycle Therapeutics reports Q2 EPS ($1.14) vs FactSet ($0.95) [13 est, ($1.13)-(0.69)] ($7.46, 0.00)

• 04:54 AM ET May 29, 2025
  

  RBC Capital Markets transfers ADCT, BCYC, CATX, others

• 07:05 AM ET May 01, 2025
  

  Bicycle Therapeutics reports Q1 EPS ($0.88) vs FactSet ($0.85) [11 est, ($1.00)-(0.61)] ($8.56, 0.00)

• 07:18 AM ET Apr 29, 2025
  

  Bicycle Therapeutics announces presentation of additional human Radiopharmaceutical imaging data for MT1-MMP at the AACR Annual Meeting 2025 ($8.40, 0.00)

• 10:25 AM ET Apr 09, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (697 total)